MRI Maker of Perioperative Neurocognitive Disorder (MRIPND)

December 11, 2018 updated by: RenJi Hospital

MRI Marker of Postoperative Delirium and Delayed Neurocognitive Recovery

Periperative neurocognitive disorder(PND) is consistently associated with increased morbidity and mortality, but its mechanisms remain unclear. Moreover, valid biomarkers for the prediction or diagnosis of the development of delayed neurocognitive recovery in aged patients have not been identified so far. The purpose of this study is trying to find the functional MRI marker of PND.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200127
        • Recruiting
        • RenJi Hospital
        • Principal Investigator:
          • Linke Chen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients elder than 60 years old elective to undergo lower limb surgery and conform to the including criteria would be recruited.

Description

Inclusion Criteria:

  • Age ≥ 60 years
  • Spoke proficient Chinese
  • Selected to lower limb osteopathic surgery
  • Informed consent signed by the patient
  • Underwent general anesthesia

Exclusion Criteria:

  • Existing cerebral disease, or have a history of neurological and psychiatric diseases including AD, stroke, and psychosis
  • Existing cognitive impairment as evidenced by Mini-Mental State Examination scores below 24
  • Several audition or vision disorder
  • With standard contraindications to MRI examinations
  • Unwillingness to comply with the protocol or procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MRI markers of PND before 7th day after surgery
Time Frame: From the day before surgery to the 7th day after surgery
To analysis the association of volume of hippocampus measured by MRI and the occurrence of PND identified at the 7th day after surgery
From the day before surgery to the 7th day after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MRI markers of PND before 12 month after surgery
Time Frame: From the 7th day after surgery to 12 month after surgery
To analysis the association of volume of hippocampus measured by MRI and the occurrence of PND identified at the 12 months after surgery
From the 7th day after surgery to 12 month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: qi lu, Dr., Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2018

Primary Completion (Anticipated)

December 30, 2019

Study Completion (Anticipated)

July 30, 2020

Study Registration Dates

First Submitted

December 10, 2018

First Submitted That Met QC Criteria

December 10, 2018

First Posted (Actual)

December 12, 2018

Study Record Updates

Last Update Posted (Actual)

December 13, 2018

Last Update Submitted That Met QC Criteria

December 11, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

3
Subscribe